Description:
The menopause test is a noninvasive saliva hormone test that examines three specimens for levels of ß-estradiol, estrone, estriol, progesterone, and testosterone. Results can be used in treatment to detect hormone imbalances that contribute to menopausal symptoms as well as various systemic disorders. By identifying hormonal imbalances practitioners can customize a hormone replacement therapy (HRT) program.
By the time a woman reaches menopause, her total estrogen production has typically declined by 70-80% and her androgen production by 50%. Reduced hormonal levels are associated with increased risk for osteoporosis and cardiovascular disease. In addition, potential functional impairments include:
- Immune regulation
- Mood control
- Glycemic control
- Sex drive
- Cognition
Establishing baseline hormone measurements of estrogens, progesterone, and testosterone is critical in determining the need for hormone replacement therapy (HRT). Hormone levels may be normal, indicating that hormone replacement therapy (HRT) is not needed. Reference ranges are based on non-supplementing post-menopausal women. Excess levels of estradiol, estrone, or testosterone may signify a higher risk of breast or endometrial cancer.